publication venue for
- Trastuzumab-refractory HER2-positive metastatic breast cancer - Use of tanespimycin, a novel Hsp90 inhibitor. 7. 2008
- Predicting sentinel lymph node metastasis. 7. 2008
- Analysis of prognostic factors and survival outcome following secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer. 6. 2007
- Bevacizumab with chemotherapy in the treatment of advanced gastric and gastroesophageal junction adenocarcinoma. 6. 2007
- Phase III randomized trial in patients with poor-prognosis metastatic germ cell tumors. 6. 2007